ES2058205T3 - Emulsion de grasa isotonica que contiene acidos grasos omega-3 y su utilizacion. - Google Patents
Emulsion de grasa isotonica que contiene acidos grasos omega-3 y su utilizacion.Info
- Publication number
- ES2058205T3 ES2058205T3 ES88116623T ES88116623T ES2058205T3 ES 2058205 T3 ES2058205 T3 ES 2058205T3 ES 88116623 T ES88116623 T ES 88116623T ES 88116623 T ES88116623 T ES 88116623T ES 2058205 T3 ES2058205 T3 ES 2058205T3
- Authority
- ES
- Spain
- Prior art keywords
- fatty acids
- omega
- triunsaturated
- eicosanoids
- triglycerides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Marine Sciences & Fisheries (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
- Extraction Or Liquid Replacement (AREA)
- Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LAS EMULSIONES GRASAS ISOTONICAS HABITUALES, QUE CONTIENEN ESENCIALMENTE ACIDOS OMEGA-3-GRASOS, POR EJEMPLO EN FORMA DE EPA, PUEDEN REACCIONAR IN VIVO A EICOSANOIDAS TRIPLEMENTE NO SATURADAS SOLO DE FORMA INSUFICIENTE, YA QUE EN EL CUERPO SE USAN PREFERENTEMENTE PARA EL METABOLISMO DE ENERGIA, ESTO ES, SE OXIDAN. MEDIANTE LA COMBINACION DE ACIDOS OMEGA-3-GRASOS O DE SUS ESTERES FISIOLOGICAMENTE INOFENSIVOS CON TRIGLICERIDOS DE CADENA MEDIA SE OXIDAN EN EL ORGANISMO PREFERENTEMENTE LOS TRIGLICERIDOS DE CADENA MEDIA, PROTEGIENDO LOS ACIDOS OMEGA-3-GRASOS DE UNA OXDACION RAPIDA, DE FORMA QUE ESTAN DISPONIBLES PARA LA FORMACION DE EICOSANOIDAS TRIPLEMENTE NO SATURADOS. ADEMAS SE CONSIGUE MEDIANTE LA COMBINACION UN EFECTO PROTECTOR DEL HIGADO. LAS EMULSIONES GRASAS ISOTONICAS CON ACIDOS OMEGA-3-GRASOS SE USAN EN ESPECIAL PARA SU APLICACION PARENTERAL EN EL METABOLISMO POST-AGRESION EN ENFERMEDADES INFECCIOSAS CRONICAS, ASI COMO EN LA NEONATOLOGIA Y EN PEDIATRIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3734147A DE3734147C2 (de) | 1987-10-09 | 1987-10-09 | Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2058205T3 true ES2058205T3 (es) | 1994-11-01 |
Family
ID=6337948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88116623T Expired - Lifetime ES2058205T3 (es) | 1987-10-09 | 1988-10-07 | Emulsion de grasa isotonica que contiene acidos grasos omega-3 y su utilizacion. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5874470A (es) |
EP (1) | EP0311091B1 (es) |
AT (1) | ATE90559T1 (es) |
DE (2) | DE3734147C2 (es) |
DK (1) | DK563388A (es) |
ES (1) | ES2058205T3 (es) |
FI (1) | FI884617A (es) |
NO (1) | NO884494L (es) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3901048A1 (de) * | 1989-01-14 | 1990-07-19 | Chimicasa Gmbh | Antikachectikum |
DE3903057A1 (de) * | 1989-02-02 | 1990-08-09 | Braun Melsungen Ag | Fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung |
DE3903056A1 (de) * | 1989-02-02 | 1990-08-09 | Braun Melsungen Ag | Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung |
DE4022815A1 (de) * | 1990-07-18 | 1992-01-23 | Braun Melsungen Ag | Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen |
DE4042437A1 (de) * | 1990-07-18 | 1992-06-11 | Braun Melsungen Ag | Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen |
GB9026648D0 (en) * | 1990-12-07 | 1991-01-23 | Efamol Holdings | Nutrition |
US5922345A (en) * | 1990-12-07 | 1999-07-13 | Scotia Holdings Plc | Nutrition |
DE4133694C2 (de) * | 1991-10-11 | 1993-10-07 | Fresenius Ag | Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen |
US5223285A (en) * | 1992-03-31 | 1993-06-29 | Abbott Laboratories | Nutritional product for pulmonary patients |
WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
DE59306981D1 (de) * | 1992-04-28 | 1997-08-28 | Fresenius Ag | Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen |
US5574065A (en) * | 1994-04-21 | 1996-11-12 | Clintec Nutrition Co. | Method and composition for normalizing injury response |
EP0689835A3 (en) * | 1994-06-30 | 1996-04-17 | Ajinomoto Kk | Composition containing an amino acid mixture and at least one N-3 fatty acid |
DE19501288A1 (de) * | 1995-01-18 | 1996-07-25 | Beiersdorf Ag | Fettsäurederivate enthaltende Lotionen |
DE19503993A1 (de) * | 1995-02-08 | 1996-08-14 | Johann Friedrich Dr Med Desaga | Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen |
DE19612340A1 (de) | 1995-03-31 | 1996-11-07 | Schuer Joerg Peter Prof | Verfahren zur Haltbarkeitsverbesserung und/oder Stabilisierung von mikrobiell verderblichen Produkten |
BR9611826A (pt) * | 1995-11-28 | 1999-07-13 | Braun Melsungen Ag | Emulsões de lipído otimizadas quanto a hidrólise e seu uso |
DE19629433A1 (de) * | 1996-07-22 | 1998-01-29 | Hoechst Ag | Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier |
ATE221324T1 (de) * | 1996-11-20 | 2002-08-15 | Nutricia Nv | Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms |
US6080787A (en) * | 1997-02-21 | 2000-06-27 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
DE19931185A1 (de) | 1999-07-07 | 2001-01-18 | Joerg Peter Schuer | Verfahren zur Entkeimung von Luft |
DE19940605A1 (de) | 1999-08-27 | 2001-03-01 | Joerg Peter Schuer | Imprägnierungsverfahren |
DE10010127B4 (de) * | 2000-03-03 | 2007-12-13 | Wedeco Ag Water Technology | UV-Bestrahlungsvorrichtung für die Behandlung von Abwasser |
AU7302801A (en) * | 2000-06-26 | 2002-01-08 | Omegatech Inc | Improved methods of incorporating polyunsaturated fatty acids in milk |
NO313934B1 (no) * | 2001-03-15 | 2002-12-30 | Pronova Biocare As | Hudpleiemiddel i form av en emulsjon, fremgangsmåte for fremstilling av nevnte hudpleiemiddel, samt anvendelse deav |
US7799365B2 (en) * | 2001-04-06 | 2010-09-21 | Burnbrae Farms Limited | Liquid egg composition including fish oil with omega-3 fatty acid |
EP1279400A1 (en) * | 2001-07-25 | 2003-01-29 | Target Hit sa | Modifying the fatty acid composition of cell membranes of organs and tissues |
CA2508907A1 (en) * | 2001-11-08 | 2003-05-15 | Atrium Medical Corporation | Intraluminal device with a coating containing a therapeutic agent |
US7323206B1 (en) | 2003-03-04 | 2008-01-29 | B. Braun Medical Inc. | Reagents and methods for all-in-one total parenteral nutrition for neonates and infants |
US8921422B2 (en) * | 2003-10-01 | 2014-12-30 | The Iams Company | Methods and kits for enhancing ability to learn in a puppy or kitten |
AU2004289353B2 (en) | 2003-11-12 | 2011-02-10 | Children's Medical Center Corporation | Treatment and prevention of liver disease associated with parenteral nutrition (PN) |
GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
US20090011116A1 (en) * | 2004-09-28 | 2009-01-08 | Atrium Medical Corporation | Reducing template with coating receptacle containing a medical device to be coated |
WO2006036970A2 (en) * | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Method of thickening a coating using a drug |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US20060067976A1 (en) * | 2004-09-28 | 2006-03-30 | Atrium Medical Corporation | Formation of barrier layer |
US8367099B2 (en) * | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
US9592324B2 (en) * | 2006-11-06 | 2017-03-14 | Atrium Medical Corporation | Tissue separating device with reinforced support for anchoring mechanisms |
US9012506B2 (en) * | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US20060088596A1 (en) | 2004-09-28 | 2006-04-27 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
US9801982B2 (en) * | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
GB0425658D0 (en) * | 2004-11-22 | 2004-12-22 | Stanford Rook Ltd | Immunotherapeutic agent |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
EP1933991A4 (en) | 2005-10-15 | 2012-05-02 | Atrium Medical Corp | HYDROPHOBIC NETWORKED GEL FOR BIOABSORBIBLE MEDICINAL CARRIER COVERS |
PT1800675E (pt) | 2005-12-23 | 2011-08-30 | Nutricia Nv | COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA |
US8221809B2 (en) * | 2006-06-22 | 2012-07-17 | Martek Biosciences Corporation | Encapsulated labile compound compositions and methods of making the same |
US9492596B2 (en) * | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
DE102008057867A1 (de) * | 2008-11-18 | 2010-05-20 | B. Braun Melsungen Ag | Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten |
US20110071090A1 (en) * | 2009-03-11 | 2011-03-24 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle |
US9034389B2 (en) | 2009-03-11 | 2015-05-19 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
US8993625B2 (en) | 2009-03-11 | 2015-03-31 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
US8241672B2 (en) * | 2009-03-11 | 2012-08-14 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
WO2011133841A2 (en) * | 2010-04-23 | 2011-10-27 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Intravenous omega-3 fatty acid compositions & method of use |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
WO2012125020A1 (en) * | 2011-03-14 | 2012-09-20 | N.V. Nutricia | Method for treating neurotrauma |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
GB201216385D0 (en) | 2012-09-13 | 2012-10-31 | Chrysalis Pharma Ag | A pharmaceutical composition |
CA2937267A1 (en) * | 2014-01-28 | 2015-08-06 | Fresenius Kabi Deutschland Gmbh | Composition comprising epa and dha ethylester for parenteral administration |
CN105939705B (zh) * | 2014-01-28 | 2020-03-17 | 费森尤斯卡比德国有限公司 | 用于肠胃外给药的包含epa甘油三酯和dha甘油三酯的组合物 |
WO2019032959A1 (en) | 2017-08-10 | 2019-02-14 | The Children's Medical Center Corporation | METHODS AND COMPOSITIONS RELATING TO EMULSIONS COMPRISING FISH OIL AND / OR OMEGA-3 FATTY ACIDS |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2033745B (en) * | 1978-05-26 | 1983-08-17 | Wellcome Found | Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions |
FR2515174A1 (fr) * | 1981-10-23 | 1983-04-29 | Roussel Uclaf | Nouveaux triglycerides, procede de preparation et d'applications en dietetique et en therapeutique |
GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
JPS59172416A (ja) * | 1983-03-18 | 1984-09-29 | Terumo Corp | 脂肪輸液 |
US4526902A (en) * | 1983-10-24 | 1985-07-02 | Century Laboratories, Inc. | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
EP0145873B1 (en) * | 1983-12-16 | 1989-01-04 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Transfusion emulsion |
US4703062A (en) * | 1984-01-16 | 1987-10-27 | Baxter Travenol Laboratories, Inc. | Parenteral nutrition with medium and long chain triglycerides |
US4871768A (en) * | 1984-07-12 | 1989-10-03 | New England Deaconess Hospital Corporation | Dietary supplement utilizing ω-3/medium chain trigylceride mixtures |
US4920098A (en) * | 1986-09-17 | 1990-04-24 | Baxter International Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases |
DE3721137A1 (de) * | 1987-06-26 | 1989-01-05 | Dietl Hans | Fettemulsion zur intravenoesen anwendung |
DE3722540A1 (de) * | 1987-07-08 | 1989-01-19 | Fresenius Ag | Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung |
US5574065A (en) * | 1994-04-21 | 1996-11-12 | Clintec Nutrition Co. | Method and composition for normalizing injury response |
-
1987
- 1987-10-09 DE DE3734147A patent/DE3734147C2/de not_active Expired - Fee Related
-
1988
- 1988-10-07 EP EP88116623A patent/EP0311091B1/de not_active Revoked
- 1988-10-07 ES ES88116623T patent/ES2058205T3/es not_active Expired - Lifetime
- 1988-10-07 FI FI884617A patent/FI884617A/fi not_active Application Discontinuation
- 1988-10-07 DE DE8888116623T patent/DE3881815D1/de not_active Revoked
- 1988-10-07 AT AT88116623T patent/ATE90559T1/de not_active IP Right Cessation
- 1988-10-07 DK DK563388A patent/DK563388A/da not_active Application Discontinuation
- 1988-10-07 NO NO88884494A patent/NO884494L/no unknown
-
1994
- 1994-09-06 US US08/301,185 patent/US5874470A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3734147A1 (de) | 1989-04-20 |
FI884617A0 (fi) | 1988-10-07 |
EP0311091B1 (de) | 1993-06-16 |
DK563388D0 (da) | 1988-10-07 |
DE3881815D1 (de) | 1993-07-22 |
DE3734147C2 (de) | 1998-10-29 |
FI884617A (fi) | 1989-04-10 |
NO884494L (no) | 1989-04-10 |
EP0311091A1 (de) | 1989-04-12 |
US5874470A (en) | 1999-02-23 |
DK563388A (da) | 1989-04-10 |
ATE90559T1 (de) | 1993-07-15 |
NO884494D0 (no) | 1988-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2058205T3 (es) | Emulsion de grasa isotonica que contiene acidos grasos omega-3 y su utilizacion. | |
Ziboh et al. | Dose-response effects of dietary γ-linolenic acid—enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4 | |
ES2173673T3 (es) | Mezcla grasa y agentes dieteticos o farmaceuticos que las contienen. | |
Schrade et al. | Fatty-acid distribution in the lipid fractions of healthy persons of different age, patients with atherosclerosis and patients with idiopathic hyperlipidaemia | |
NL990032I1 (nl) | Vetemulsie, werkwijze voor de bereiding daarvan ende toepassing daarvan. | |
PT843972E (pt) | Composicao nutritiva que inclui gorduras para o tratamento do sindrome metabolico | |
DK1809125T3 (da) | Næringsmiddel, der indeholder en fedtblanding | |
KR940018090A (ko) | 트리글리세라이드 | |
GR1000567B (el) | Συνθεσις λιπαρου οξεος. | |
DK1121115T3 (da) | PUFA-tilskud | |
SE8405308D0 (sv) | Farmaceutisk komposition och forfarande for framstellning av densamma | |
CA2147302A1 (en) | A lipid composition for normalizing injury | |
ATE167983T1 (de) | Phospholipidhaltige fettmischung mit lcp- fettsäuren | |
DE3470277D1 (en) | Dietetic composition | |
DE69927665D1 (de) | Stabilisierte Fettmischung, Methode zu ihrer Herstellung und Lebensmittel, welches das Fett enthält | |
ES2037265T3 (es) | Nuevo aceite dietetico. | |
Du et al. | Effect of dietary oils enriched with n-3 fatty acids on survival of mice | |
Galli et al. | General recommendations on dietary fats for human consumption | |
STZ et al. | Supplementary Table S2 ESM Table 2. Retinal lipid assay. | |
TH15808A (th) | ไทรกลีเซอไรด์ กรรมวิธีสำหรับการผลิต c-ซับสทิทิวเทดไดเอธิลีนไทรแอมีน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 311091 Country of ref document: ES |